Save Dihexa is an angiotensin-IV-derived oligopeptide marketed as a research nootropic, and its honest safety picture starts with an absence: there are no published human clinical trials of Dihexa, and therefore no human safety, toxicology, or pharmacokinetic data of any kind
Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione-S-transferase, and epoxide hydrolase enzymes: relevance to xenobiotic metabolism and toxicity
Otto MW, Basden SL, Leyro TM, McHugh RK, Hofmann SG (2007)
If using injections for cosmetic purposes: reconsider share this article with your clinician and weigh benefits vs risks carefully
However, this side effect is not common and can be minimized by consulting with your physician on prescribing right injection dose